Soutenir la recherche

Publications et ressources

Trier par :
Afficher :
131-140 sur 397

Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.

D Saadoun, S Pol, Y Ferfar, L Alric, Christophe HEZODE, SN Si Ahmed, L De Saint Martin, C Comarmond, AS Bouyer, L Musset, T Poynard, M Resche-Rigon, P Cacoub,

Gastroenterology. 01/07/2017;153(1) : 49-52.e5 10.1053/j.gastro.2017.03.006. 10/03/2017

When activated oncogene meets immunity: a fight to prevent liver tumor initiation

JC Nault, Giuliana AMADDEO, J Zucman-Rossi,

Hepatology. 01/07/2017;56(1) : 387-389 .

Renal Medullary Carcinoma: Establishing Standards in Practice

KE Beckermann, D Sharma, S Chaturvedi, P Msaouel, MR Abboud, Y Allory, F Bourdeaut, Julien CALDERARO, AA De Cubas, K Derebail, AL Hong, RP Naik, GG Malouf, EA Mullen, VE Reuter, CWM Roberts, CL Walker, CG Wood, MR DeBaun, H Van Poppel, NM Tannir, WK Rathmell,

J Oncol Pract. 01/07/2017;13(7) : 414-421 10.1200/JOP.2017.020909.

PD-L1 Expression and CD8+ T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate Cancer

F Petitprez, Y Vano, M Freschi, E Becht, R Luciano, Julien CALDERARO, T Guedet, L Lacroix, PMV Rancoita, F Montorsi, WH Fridman, C Sautes-Fridman, A Briganti, C Doglioni, M Bellone,

Eur Urol Focus. 21/06/2017;pii: S2405-4569(17) : 30151-7. 10.1016/j.euf.2017.05.013.

Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.

Christophe HEZODE, Slim FOURATI, Stephane CHEVALIEZ, G Scoazec, Alexandre SOULIER, A Varaut, M Francois, Isaac RUIZ, F Roudot-Thoraval, A Mallat, Jean-Michel PAWLOTSKY,

Clin Infect Dis. 01/06/2017;64(11) : 1615-1618 10.1093/cid/cix214. 24/07/2017

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.

L Assoumou, C Charpentier, P Recordon-Pinson, M Grude, C Pallier, L Morand-Joubert, S Fafi-Kremer, A Krivine, B Montes, V Ferre, Magali BOUVIER-ALIAS, JC Plantier, J Izopet, MA Trabaud, S Yerly, J Dufayard, C Alloui, L Courdavault, H Le Guillou-Guillemette, A Maillard, C Amiel, A Vabret, C Roussel, S Vallet, J Guinard, A Mirand, A Beby-Defaux, F Barin, A Allardet-Servent, R Ait-Namane, M Wirden, C Delaugerre, V Calvez, ML Chaix, D Descamps, S Reigadas,

j Antimicrob Chemother. 01/06/2017;72(6) : 1769-1773 10.1093/jac/dkx042.

Complications after Hepatectomy for Hepatocellular Carcinoma Independently Shorten Survival: A Western, Single-Center Audit.

A Doussot, C Lim, E Lahat, C Salloum, M Osseis, CG Gavara, E Levesque, Cyrille FERAY, P Compagnon, D Azoulay,

Ann Surg Oncol. 01/06/2017;24(6) : 1569-1578 10.1245/s10434-016-5746-6 05/01/2017

Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas

C Neuzillet, Benoit ROUSSEAU, HM Kocher, P Bourget, C Tournigand,

Pharmacol Tger. 01/06/2017;174 : 145-172 10.1016/j.pharmthera.2017.02.028 14/02/2017

Fine-Scale Structure Analysis Shows Epidemic Patterns of Clonal Complex 95, a Cosmopolitan Escherichia coli Lineage Responsible for Extraintestinal Infection

SC Gordon, S Geyik, O Clermont, CL O'Brien, S Huang, C Abayasekara, M Rajesh, K Kennedy, P Collignon, P Pavli, Christophe RODRIGUEZ, BD Johnston, JR Johnson, JW Decousser, E Denamur,

mSphere 31/05/2017;2(3) : pii: e00168-17 10.1128/mSphere.00168-17

Afficher :
131-140 sur 397